X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

Merck Opens Production Facility for Liquid Crystal Window Modules

Yuvraj_pawp by Yuvraj_pawp
30th November 2017
in Facilities & Operation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Merck, a leading science and technology company, today opened a new production facility for liquid crystal window modules in Veldhoven, near Eindhoven, in the Netherlands. The investment of around € 15 million is a further step by Merck to expand its expertise as the market and technology leader in liquid crystals for displays by moving into other applications beyond televisions, laptops, smartphones, and tablet PCs. In 2016, an independent business field was set up for liquid crystal window technology in order to achieve faster market penetration. Merck is the world’s first supplier of this window module technology, which in comparison with previous technologies, offers new application possibilities and regulation within seconds.

Deliveries to start in 2018
“This new facility is a milestone in our strategy to capture new attractive and future-oriented application fields for liquid crystals beyond displays,” emphasized Kai Beckmann, Member of the Executive Board of Merck and CEO Performance Materials, during the inauguration attended by around 100 invited guests from business and politics. “We recently started taking orders from customers for modules that will be ready for delivery as of early 2018. The industry interest in liquid crystal windows we’ve seen so far is very positive.”

Globally, the demand for smart glass is rising. In particular, the construction and automotive industries are looking for long-lived elements that can be integrated both aesthetically and functionally in many shapes and colors. Merck does not see itself as a competitor to glass and window manufacturers, but rather will supply the modules enabling them to make these smart glass elements, windows and façades. In addition, Merck assists architects, designers as well as window and façade makers in an advisory capacity.

For sun protection and privacy applications
In smart glass, liquid crystals regulate light transmission. It serves either as sun or privacy protection. Both variants, which respond within seconds, offer users maximum convenience.

In sun protection applications, exterior blinds and their costly maintenance and repair are unnecessary. The light transmittance of the windows can be lowered down to 5% and set in a continuously variable manner. Energy savings of up to 40% are thus possible with building climate control systems. In both the dark and the bright state, the windows remain transparent and color-neutral and provide an unhindered view outside. Of particular interest to architects is their tremendous flexibility in terms of size and shape as well as the possibilities of their color design with no effect on transparency – a further advantage in addition to switching within seconds – over competing technologies. The privacy variant also switches within seconds from transparent to opaque. It prevents outsiders from being able to look inside conference rooms, restricted production areas or residential buildings.

The liquid crystal materials, which are marketed under the licrivisionTM brand, are also to be used in vehicles in the future. Research is currently underway for further application possibilities, for instance in air and sea travel.

Recognition as an important innovation driver
Long-term tests under real conditions show that innovative liquid crystal windows also live up to their promise in practical applications. Since 2015, the liquid crystal windows in the western façade of Merck’s modular Innovation Center in Darmstadt have been operating perfectly even on hot summer days and icy-cold winter nights. In September 2016, the sun protection and privacy variants were installed in the new OLED production building at the Darmstadt site.

Frost & Sullivan, a global consultancy, has also recognized the potential of the new breakthrough technology. At the end of October, it presented the “Technology Innovation Award” to Merck for its liquid crystal window technology. According to the jury, as a key innovation driver with significant competitive advantage in smart glass, Merck has the opportunity to establish itself as a market leader.

Previous Post

Vaccinex And Catalent Biologics To Collaborate On Antibody-Drug Conjugate Development

Next Post

SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

Related Posts

API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
API Manufacturing Facility
Americas

Lilly to Build $6.5B API Manufacturing Facility in Houston

25th September 2025
Merck and Siemens
Drug Development

Merck and Siemens to Accelerate AI Driven Drug Development

24th September 2025
Scottish Pharma Sector
Europe

ABPI Launches Manifesto to Advance Scottish Pharma Sector

23rd September 2025
Automating Experimental Design with Generative AI in Pharma
Facilities & Operation

Automating Experimental Design with Generative AI in Pharma

20th September 2025
Next Post
SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In